| Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer DS Yim, SK Park, KY Yoo, KS Yoon, HH Chung, HJ Kang, SH Ahn, ... Pharmacogenetics and Genomics 11 (4), 279-286, 2001 | 152 | 2001 |
| Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum JH Yi, J Lee, SH Park, JO Park, DS Yim, YS Park, HY Lim, WK Kang British Journal of Cancer 106 (9), 1469-1474, 2012 | 142 | 2012 |
| Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19 KS Yu, DS Yim, JY Cho, SS Park, JY Park, KH Lee, IJ Jang, SY Yi, KS Bae, ... Clinical Pharmacology & Therapeutics 69 (4), 266-273, 2001 | 107 | 2001 |
| Population pharmacokinetic analysis and simulation of the time‐concentration profile of etanercept in pediatric patients with juvenile rheumatoid arthritis DS Yim, H Zhou, M Buckwalter, I Nestorov, CC Peck, H Lee The Journal of Clinical Pharmacology 45 (3), 246-256, 2005 | 97 | 2005 |
| Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients SH Kim, DS Yim, SM Choi, JC Kwon, S Han, DG Lee, C Park, EY Kwon, ... International Journal of Infectious Diseases 15 (11), e753-e758, 2011 | 83 | 2011 |
| Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004–2006 Y Wang, AV Bhattaram, PR Jadhav, LJ Lesko, R Madabushi, JR Powell, ... The Journal of Clinical Pharmacology 48 (2), 146-156, 2008 | 83 | 2008 |
| Population pharmacokinetics of meropenem in burn patients K Doh, H Woo, J Hur, H Yim, J Kim, H Chae, S Han, DS Yim Journal of antimicrobial chemotherapy 65 (11), 2428-2435, 2010 | 69 | 2010 |
| Omeprazole hydroxylation is inhibited by a single dose of moclobemide in homozygotic EM genotype for CYP2C19 JY Cho, KS Yu, IJ Jang, BH Yang, SG Shin, DS Yim British journal of clinical pharmacology 53 (4), 393-397, 2002 | 62 | 2002 |
| A population pharmacokinetic–pharmacodynamic model for simvastatin that predicts low‐density lipoprotein‐cholesterol reduction in patients with primary hyperlipidaemia J Kim, BJ Ahn, HS Chae, S Han, K Doh, J Choi, YK Jun, YW Lee, DS Yim Basic & clinical pharmacology & toxicology 109 (3), 156-163, 2011 | 51 | 2011 |
| Combined effect of GSTM1, GSTT1, and COMT genotypes in individual SK Park, D Yim, K Yoon, I Choi, J Choi, K Yoo, D Noh, K Choe, S Ahn, ... Breast cancer research and treatment 88, 55-62, 2004 | 51 | 2004 |
| Population pharmacokinetics of intravenous valproic acid in Korean patients HM Park, SS Kang, YB Lee, DJ Shin, ON Kim, SB Lee, DS Yim Journal of clinical pharmacy and therapeutics 27 (6), 419-425, 2002 | 49 | 2002 |
| Erythrocyte thiopurine methyltransferase activity in a Korean population IJ Jang, SG Shin, KH Lee, DS Yim, MS Lee, HH Koo, HK Kim, DR Sohn British journal of clinical pharmacology 42 (5), 638-641, 1996 | 42 | 1996 |
| CYP1A2 activity as a risk factor for bladder cancer SW Lee, IJ Jang, SG Shin, KH Lee, DS Yim, SW Kim, SJ Oh, SH Lee Journal of Korean medical science 9 (6), 482-489, 1994 | 41 | 1994 |
| Population pharmacokinetic analysis of colistin in burn patients J Lee, S Han, S Jeon, T Hong, W Song, H Woo, DS Yim Antimicrobial agents and chemotherapy 57 (5), 2141-2146, 2013 | 39 | 2013 |
| System for managing inter-company settlement and the method therefor D Yim US Patent App. 10/203,824, 2003 | 38 | 2003 |
| Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients SJ Lee, J Lee, J Lee, SH Park, JO Park, YS Park, HY Lim, KM Kim, IG Do, ... Investigational new drugs 31, 1580-1586, 2013 | 37 | 2013 |
| What does it take to make model-informed precision dosing common practice? Report from the 1st Asian symposium on precision dosing TM Polasek, A Rostami-Hodjegan, DS Yim, M Jamei, H Lee, H Kimko, ... The AAPS journal 21, 1-9, 2019 | 35 | 2019 |
| Population pharmacokinetics of meropenem in febrile neutropenic patients in Korea DG Lee, SM Choi, WS Shin, HO Lah, DS Yim International journal of antimicrobial agents 28 (4), 333-339, 2006 | 35 | 2006 |
| Model-based adaptive phase I trial design of post-transplant decitabine maintenance in myelodysplastic syndrome S Han, YJ Kim, J Lee, S Jeon, T Hong, G Park, JH Yoon, SA Yahng, ... Journal of Hematology & Oncology 8, 1-9, 2015 | 34 | 2015 |
| Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β‐cyclodextrin in haematological patients with renal impairment SH Kim, JC Kwon, C Park, S Han, DS Yim, JK Choi, SY Cho, HJ Lee, ... Mycoses 59 (10), 644-651, 2016 | 33 | 2016 |
